SEOUL, Feb. 13 (Korea Bizwire) — Three homegrown treatments for the novel coronavirus are expected to receive approval as early as the first half of this year as the country speeds up the approval process amid the pandemic. Last week, the country’s drug safety agency approved pharmaceutical giant Celltrion Inc.’s CT-P59, an anti-COVID-19 monoclonal antibody [...]
SEOUL, Feb. 11 (Korea Bizwire) — A recent study found that Bisphenol A (BPA), an endocrine disrupting chemical referred to as an environmental hormone, raises the obesity risk for adults. BPA-based plastics are used to make food containers, water bottles, sports equipment, CDs and DVDs. A research team from the Inje University Sanggye Paik Hospital [...]
SEOUL, Feb. 10 (Korea Bizwire) — Researchers from Seoul National University Hospital said Tuesday that they had developed a program that offers computer game-based cognitive behavioral therapy to children struggling with depression. This program consists of a series of training exercises including ones dedicated to overcoming depression, making friends, and promoting learning capacity, held twice [...]
SEOUL, Feb. 10 (Korea Bizwire) — South Korea’s drug safety agency on Wednesday approved the vaccine for the novel coronavirus by AstraZeneca for all adults, including those aged 65 and older, amid efficacy controversies. The vaccine developed by the British-Swedish pharmaceutical giant and Oxford University is the first to be granted approval in the country, [...]
SEOUL, Feb. 8 (Korea Bizwire) – AstraZeneca will start delivering the first batch of its COVID-19 vaccine to South Korea starting from Feb. 24, South Korean health authorities said Monday. The virus response control tower said in a statement that AstraZeneca’s vaccine will be supplied in phases from Feb. 24 over the following several days, [...]
SEOUL, Feb. 5 (Korea Bizwire) — South Korea’s drug safety agency said Friday it has approved pharmaceutical giant Celltrion Inc.’s COVID-19 treatment candidate on several conditions. The conditional marketing authorization of CT-P59, an anti-COVID-19 monoclonal antibody treatment candidate, marks the country’s first homegrown COVID-19 treatment. The Korean Ministry of Food and Drug Safety said CT-P59 [...]
GWANGJU, Feb. 3 (Korea Bizwire) — South Korean researchers have developed new technology that enables users to verify whether a stent has become re-stenosed in a blood vessel via a smartphone. A joint research team from Chonnam National University Hospital and Chonnam National University recently announced that they had developed the world’s first monitoring technology [...]
SEOUL, Feb. 2 (Korea Bizwire) — A research team from Hanyang University, in collaboration with the University of Texas at Austin and other multinational teams, has developed a unipolar artificial muscle that is three times more powerful than other products. The joint research team discovered that coating a carbon nanotube with ion-exchange resin can allow [...]
SEOUL, Feb. 2 (Korea Bizwire) — South Korea’s drug safety agency has stepped up efforts to speed up the approval process for COVID-19 vaccines and treatments amid a third wave of coronavirus outbreaks. The Korea Disease Control and Prevention Agency (KDCA) said Tuesday it would apply for a special import procedure for Pfizer’s vaccines. The [...]
SEOUL, Feb. 1 (Korea Bizwire) — The use of smartphones, tablets, and other smart devices undermine our eyes’ ability to focus and exacerbate eye fatigue. A research team from Chung-ang University Hospital invited 46 healthy adults without any eye treatment records to participate in an experiment on how the use of smartphones and tablets affects [...]